NOI - B2B Award entitled - Developing Red Cell-Sp
Combined Synopsis/Solicitation. Posted by NATIONAL INSTITUTES OF HEALTH OLAO. Responses close Nov 4, 2026.
Read from the SAM.gov opportunities API, checked every hour. The original notice is linked at the foot of this page.
The notice as published
| Field | As posted |
|---|---|
| Notice type | Combined Synopsis/Solicitation |
| Solicitation number | 75N98027Q00017 |
| Posted | Oct 20, 2026 |
| Responses close | Nov 4, 2026 |
| Buying office | NATIONAL INSTITUTES OF HEALTH OLAO |
| Department | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| NAICS | 325411 Medicinal and Botanical Manufacturing |
| PSC | 6505 |
Shown exactly as the source published it. Where a field is blank on the notice it says so rather than being filled in.
Who is named on it
| Name | Role | |
|---|---|---|
| CAPOBIANCO, NICHOLAS S | not stated | nicholas.capobianco@nih.gov |
Published on the notice by the contracting office. Before the solicitation closes, contact is limited to the formal question process the notice describes.
Attachments
- AttachmentAttachment published with the notice.
NAICS 325411 in numbers
DLA Troop Support dominates this market, issuing over 2.1 million awards worth $46.77 billion since 2001, mostly through its medical supply channel. The CDC and the Assistant Secretary for Administration and Mgmt also buy regularly in this space. Most awards are unrestricted, though a small number go to small business set-asides. With 235 distinct vendors on record, the market shows limited competition despite the large total spend.
The median award of $1,400 signals that DLA Troop Support buys medicinal and botanical products in high volume but at low individual contract values. This is a supply-chain business, not a project business. Firms should expect frequent small orders rather than occasional large contracts. The data shows this is a stable, recurring market where vendors who can handle logistics and meet military specifications win repeat business.
Watch the 27 contracts ending within the next 12 months worth $8.66 million combined. These represent your window to compete for renewals or to displace existing vendors. The two active notices currently posted may signal new opportunities or upcoming recompetes. Given DLA's dominance and the low award size, success here depends on operational efficiency, reliable supply, and the ability to meet federal procurement timelines and specifications.
Everything behind these numbers for NAICS 325411
- Every buying office that awarded in this code, ranked by what they spent
- Every vendor that won, resolved to one record per business
- Every award back to FY2001, searchable and exportable
- Contracts ending soon, scored for how open the next round looks
- Every open notice on this code, with the buyer history beside it
The numbers above are open to anybody. The organized record behind them is what a plan pays for: every award, every buyer, every vendor, cleaned, resolved and read again every night.
Everything else open under this code
3 open notices right now, 1 closing within seven days. The newest 5:
| Posted | Notice | Buyer | NAICS | Set-aside | Due |
|---|---|---|---|---|---|
| Oct 20, 2026 | NOI - B2B Award entitled - Developing Red Cell-SpCombined Synopsis/Solicitation | NATIONAL INSTITUTES OF HEALTH OLAO | 325411 | Nov 4, 2026 | |
| Sep 24, 2026 | 65--MIDAZOLAM INJECTIONJustification · JERUSALEM IL | DLA TROOP SUPPORT | 325411 | not stated | |
| Sep 22, 2026 | 65--MIDAZOLAM INJECTIONAward Notice | DLA TROOP SUPPORT | 325411 | not stated |
See who was last awarded in your NAICS
Every code, every buying office, every vendor and every recompete, organized from the federal record and read nightly. Start on one code with no card. A plan opens every code.
Try the live demo The real app on one code. No email needed.